About us
Laboratory of Pharmacogenomics is involved in the study and development of prognostic and predictive biomarkers for more refined evaluation of survival of cancer patients and the response of tumor cells to the therapy. Genomic, epigenomic, proteomic, and metabolomic analyses of tissue preparations from cancer patients provided by clinical collaborators from the Czech Republic are performed for this purpose. Predictive biomarkers may help clinicians in the stratification of patients into different therapeutic regimens. Discovery and validation of prognostic biomarkers may also contribute to the invention of drugs for targeted therapy. Our team has experience in this area for more than 20 years. Research activities are supported by a number of grants including Center of Excellence awarded by Czech Science Foundation (see Projects). Lab members regularly publish our results in publicly accessible scientific journals (see Publications) and collaborate with several highly respected foreign partners (see Collaborations).
Releated Research themes
Contact
Biomedical Center
alej Svobody 1655/76
323 00 Plzeň – Severní Předměstí
E: This email address is being protected from spambots. You need JavaScript enabled to view it.
T: +420 377 593 840
Members
- Prof. Pavel Souček, Ph.D., M.Sc. – Research Group Leader
- Radka Václavíková, M.Sc., Ph.D.
- Assoc. Prof. Pavel Dvořák, M.Sc., Ph.D.
- Veronika Boušková, M.Sc., Ph.D.
- Viktor Hlaváč, M.Sc., Ph.D.
- Marie Ehrlichová, M.Sc.
- Simona Šůsová, M.Sc.
- Alžběta Spálenková, M.Sc., Ph.D.
- Karolína Šeborová, M.Sc., Ph.D.
- Petr Holý, M.Sc., Ph.D.
- Tereza Tesařová, M.Sc.
- Lucie Heczko, M.Sc.
- Bhavana Hemantha Rao, M.S.
- Mohammad Moufaq Khatar Al Obeed Allah, M.D.